New Times,
New Thinking.

  1. Politics
27 October 2009

Heseltine challenges Cameron on Europe

Big beast predicts that Eurosceptic alliance will end

By George Eaton

Today’s Times reports that Lord Heseltine believes the Conservatives will have to ditch their far-right allies and return to the European People’s Party if they win power.

Is there any chance of this happening? Almost certainly not. David Cameron’s Euroscepticism continues to insulate him from right-wing dissent and keeps grass-roots Tories onside. Heseltine’s prediction is a case of of the wish being father to the thought.

As I’ve noted before, the Conservatives’ pro-European wing has been vanquished. It lacks the capacity to force a policy reversal. Cameron may well further alienate Angela Merkel and Nicolas Sarkozy, but given his emphasis on political consistency, he is unlikely to cite Keynes’s dictum: “When the facts change, I change my mind. What do you do, sir?”

In fairness, it is doubtful that Heseltine himself believes Cameron will back down. It’s far more likely that his intervention is designed to prompt Europhile dissent elsewhere in the party. In any case, such mischief-making proves that Hezza doesn’t regard his position on Europe as a barrier to his return to government.

Select and enter your email address Your weekly guide to the best writing on ideas, politics, books and culture every Saturday. The best way to sign up for The Saturday Read is via saturdayread.substack.com The New Statesman's quick and essential guide to the news and politics of the day. The best way to sign up for Morning Call is via morningcall.substack.com
Visit our privacy Policy for more information about our services, how Progressive Media Investments may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications.
THANK YOU

Content from our partners
Unlocking investment in UK life sciences through manufacturing
Data defines a new era for fundraising
A prescription for success: improving the UK's access to new medicines